News

U.S. Sen. Raphael Warnock just introduced a bill that would cap Americans’ out-of-pocket spending on insulin at $35 a month. The...

The Federal Trade Commission recently requested public comments on the effect of drug-industry middlemen on drug affordability and...

“Among other provisions, this bill would direct the Federal Trade Commission (FTC) to launch a study and report to Congress on the...

U.S. Sen. Ron Wyden (D-OR) is urging the Centers for Medicare and Medicaid Services (CMS) to finalize the proposal that applies all...

Too many people go to the pharmacy counter only to be told the cost of their prescription medicine has gone up. Again. It’s maddening at...

Following the Federal Trade Commission’s decision to not, at least initially, dig deeper into pharma middlemen known as PBMs, the...

Pharmacy benefit managers — liaisons between pharmaceutical companies and health insurers that run patients’ prescription benefits — are...

In the last 4 years, the three biggest pharmacy benefit managers have consolidated influence in the U.S. health care marketplace through...

New Report from the Community Oncology Alliance studies "How PBMs Adversely Impact Cancer Care While Profiting at the Expense of...

Last week a pharmaceutical industry expert named Antonio Ciaccia, testified in front of the Indiana General Assembly about a bill that...

Chronic hepatitis B (CHB) causes significant liver-related morbidity and mortality. Treatment of CHB is cost-effective in the US;...

West Virginia Senator Joe Manchin recently announced he won't support the current version of the Build Back Better Act. When they heard...

The entities charged with negotiating better drug prices for consumers are pocketing the savings for themselves. Antonio Ciaccia,...

The doctor or practitioner writes the prescription, you take it to the pharmacy, and you get the medication you need. Simple, right? You...

Pharmacy Benefit Managers are companies that manage prescription drug benefits on behalf of insurers. But a new report finds they may be...

Pharmaceutical middlemen saw gross profits increase by 12% from 2017 to 2019, according to a report by the PBM Accountability Project ....

Misaligned Incentives Allowed PBM Gross Profit to Grow 12% in Just Two Years MEDIA CONTACT: Mike Kapsa 443-333-9769...

If you have health insurance the chances are high that it is managed by a ‘Pharmacy Benefit Manager’. PBM’s are connectors between drug...

Most everyone knows the story of Robin Hood who stole from the rich to give to the poor. But what do you call someone who picks the...

An economic threat that consumers have not had to worry about for quite some time – inflation – may become a reality. From groceries to...

"Even with substantive communication and (county-owned) data restrictions, we were able to quantify over $1.4 million in savings: During...

Earlier this month, a Medicare recipient with drug coverage filled a prescription at a Concord branch of a major pharmacy chain. The ...

(Bloomberg) -- Robyn Curtis, a staff adviser at the University of Southern Mississippi in Hattiesburg, has a 13-year-old daughter with...